Will the FDA approve a drug to prevent migraine headaches by 2025? | Manifold

Will the FDA approve a drug to prevent migraine headaches by 2025?

Basic

3

Ṁ21

Jan 1

66%

chance

1D

1W

1M

ALL

This question is managed and resolved by Manifold.

Get

1,000

and

3.00

Sort by:

predicts YES

I'm sorry. I think you're right;. I was reading about a drug in the pipeline. II'lll resolve on any that come out. Thank you for correcting me.

Afaik there are many already. Do you mean a new one? A better one? One specifically for migraines instead of an anti-epileptic or beta blocker? The question seems very vague

Related questions

Will an AI-designed drug get FDA approval by the end of 2025?

Will the FDA approve a disease-modifying treatment for Parkinson's disease by 2025?

Will AOH1996 be FDA approved before 2040?

Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?

Pain Relief vs Addiction: Will Vertex’s non-opioid (hopefully nonaddictive) Suzetrigine/VX-548 be FDA-approved in 2024?

Will the FDA approve MDMA as a treatment for PTSD by the end of 2024?

Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030?

Will a drug to be used by most healthy adults be approved by 2043 year end?

Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.

Will the FDA approve a disease-modifying treatment for Parkinson's disease before 2029?

Related questions

Will an AI-designed drug get FDA approval by the end of 2025?

Will the FDA approve MDMA as a treatment for PTSD by the end of 2024?

Will the FDA approve a disease-modifying treatment for Parkinson's disease by 2025?

Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030?

Will AOH1996 be FDA approved before 2040?

Will a drug to be used by most healthy adults be approved by 2043 year end?

Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?

Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.

Pain Relief vs Addiction: Will Vertex’s non-opioid (hopefully nonaddictive) Suzetrigine/VX-548 be FDA-approved in 2024?

Will the FDA approve a disease-modifying treatment for Parkinson's disease before 2029?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules